Study links statins to lower risk of prostate cancer

08/22/2005 | Taiwan News

An Oregon Health Sciences University study reported statins such as Lipitor and Pravachol may cut the risk of aggressive forms of prostate cancer by as much as 62%, according to a study in the American Journal of Epidemiology. Statins previously have been linked to reduced risk of other malignancies, but this study's researchers looked specifically at prostate cancer, though they said a larger study would be needed to confirm their results.

View Full Article in:

Taiwan News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR